← Open Payments lookup

SABRINA ARNOLD: Open Payments

NPI 1811608029 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,508 in 139 payments from 18 companies in 2025. Trend: 2023 $1,200 · 2024 $1,445 · 2025 $2,508

Food & beverage: $2,429Education: $79
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP30$545
Viatris Specialty LLC16$308
GlaxoSmithKline, LLC.27$298
Grifols USA, LLC7$196
Regeneron Healthcare Solutions, Inc.13$189
Boehringer Ingelheim Pharmaceuticals, Inc.11$186
Takeda Pharmaceuticals U.S.A., Inc.8$183
GENZYME CORPORATION8$154
United Therapeutics Corporation3$99
SANOFI-AVENTIS U.S. LLC1$79

Products named: DUPIXENT, YUPELRI, FASENRA, Prolastin-C Liquid, GLASSIA, BREZTRI, NUCALA, TEZSPIRE.

Industry payments across AR — which companies pay providers there.